Hemolytic anemia during pegylated IFN-alpha2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit.
第一作者:
Ivan,Gentile
第一单位:
Department of Public Medicine and Social Security, Institute of Infectious Diseases( Ed. 18), University of Naples Federico II, Naples, Italy. borgia@unina.it
作者:
医学主题词
贫血, 溶血性, 自身免疫性(Anemia, Hemolytic, Autoimmune);抗病毒药(Antiviral Agents);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);丙型肝炎, 慢性(Hepatitis C, Chronic);人类(Humans);干扰素α(Interferon-alpha);中年人(Middle Aged);聚乙烯二醇类(Polyethylene Glycols);重组蛋白质类(Recombinant Proteins);利巴韦林(Ribavirin)
DOI
10.1089/jir.2005.25.283
PMID
15871666
发布时间
2018-12-01
- 浏览29
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



